Publication:
Atypical course of COVID-19 in patient with Bruton agammaglobulinemia

Loading...
Thumbnail Image

Date

2020

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Research Projects

Organizational Units

Journal Issue

Abstract

We present atypical course of the novel coronavirus disease (COVID-19) in 34-year man with Bruton agammaglobulinemia. The patient was successfully treated by a combination of available drugs, including convalescent plasma and interleukin-6 (IL-6) inhibitor. © 2020 Journal of Infection in Developing Countries. All rights reserved.

Description

Keywords

Agammaglobulinemia, Convalescent plasma, COVID-19, IL-6 inhibitor

Citation

URI

https://doi.org/10.3855/jidc.13840
 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85097916070&doi=10.3855%2fjidc.13840&partnerID=40&md5=63f87e25acf571249b4e7a78e788c44c
 https://remedy.med.bg.ac.rs/handle/123456789/12373

Collections

Publikacije / Publications